A randomized open-label study comparing the efficacy and safety of sirolimus combined with daclizumab, mycophenolate and corticosteroids vs cyclosporine, mycophenolate and corticosteroids in renal allograft recipients receiving kidneys from older donors.

Trial Profile

A randomized open-label study comparing the efficacy and safety of sirolimus combined with daclizumab, mycophenolate and corticosteroids vs cyclosporine, mycophenolate and corticosteroids in renal allograft recipients receiving kidneys from older donors.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Aug 2010

At a glance

  • Drugs Ciclosporin; Daclizumab; Sirolimus
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 15 Aug 2010 Results presented at the 23rd International Congress of the Transplantation Society.
    • 15 Sep 2009 Actual number of patients (61) added as reported by ClinicalTrials.gov.
    • 15 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top